What GLP-1 users should know about the potential risk of a rare type of vision lossTue, September 22, 2026 at 12:12 AM UTC Dozens of Americans have filed personal injury lawsuits against the makers of popular GLP-1 drugs, like Ozempic, Wegovy and Mounjaro, claiming they were not properly warned of the risk of a rare type of sudden vision loss, called nonarteritic anterior ischemic optic neuropathy, or NAION, when taking the medications.
Published: September 22, 2026 at 11:54AM on Source: VENUS MAG
#ShowBiz#Sports#Celebrities#Lifestyle